Pure Global
NCT05020717

Retrospective Survey of Hyperkalemia in Hemodialysis

A Multicenter Retrospective Survey of Hyperkalemia Clinical Burden on Hemodialysis Facility-level in China
Peking University People's Hospital·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hemodialysis Complication
Study type
Observational
Sponsor & location
Primary sponsor
Peking University People's Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2021
End date
Dec 01, 2022
Enrollment
300 participants
Primary outcome

To investigate the risk factors associated with hyperkalemia clinical burden on HD facility level

Summary

This study aim to describe hyperkalemia clinical burden and investigate the risk factors
 associated with the burden on HD facility level.

ICD-10 classifications
Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05020717
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05020717 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking University People's Hospital and is currently Recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.